Literature DB >> 1080432

Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T cell differentiation.

D H Schlesinger, G Goldstein, M P Scheid, E A Boyse.   

Abstract

Thymopoietin is a polypeptide hormone of the thymus that consists of a 49 amino acid polypeptide chain of 5562 daltons. A peptide corresponding to positions 29-41 of bovine thymopoietin II was synthesized by the Merrifield solid-phase technique. This peptide was shown to have a purity (correct sequence) of 96% by amino acid and C terminal analyses and by a complete determination of the amino acid sequence by manual Edman degradations. It displayed a selectivity of action similar to that of thymopoietin itself, inducing the differentiation of T lymphocytes but not of complement receptor (CR+) B lymphocytes. Although a number of substances induce the differentiation of both T cells and CR+B cells under the conditions of assay in vitro, only thymopoietin and the synthetic peptide described in this report have been shown to induce the differentiation of T cells selectively. Our data establish that the key residues involved in the active site of thymopoietin are present within a synthetic polypeptide which constitutes a minor portion of the amino acid sequence of thymopoietin. Since this peptide had 3% activity by comparison with thymopoietin, the tertiary structure of thymopoietin may be required for optimal configuration of the active site to produce full biological activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080432     DOI: 10.1016/0092-8674(75)90055-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  12 in total

1.  Direct ESR detection or peroxynitrite-induced tyrosine-centred protein radicals in human blood plasma.

Authors:  D Pietraforte; M Minetti
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

3.  Editorial: "Myasthenia gravis" or the autoimmunity, thymic disease, neuromuscular block poser.

Authors:  G Goldstein
Journal:  West J Med       Date:  1975-08

4.  Chemical synthesis of a hexadecapeptide segment of ubiquitin that activates adenylate cyclase and induces lymphocytes to differentiate.

Authors:  D H Schlesinger; G Goldstein; M P Scheid; M Bitensky
Journal:  Experientia       Date:  1978-06-15

5.  Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.

Authors:  E L Ochoa; S Medrano; M C de Carlin; A M Dilonardo
Journal:  Cell Mol Neurobiol       Date:  1988-09       Impact factor: 5.046

6.  The serum thymic factor (FTS). Chemical and biological aspects.

Authors:  J M Pleau; M Dardenne; J F Bach
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

7.  Identification of thymostimulin secreting cells in calf thymus by immunoperoxidase method.

Authors:  M Aita; D Cocchia; A B Minella; A Amantea
Journal:  Histochemistry       Date:  1984

8.  Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells.

Authors:  W Savino; M Dardenne; J F Bach
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.

Authors:  T M Jackson; S N Zaman
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

10.  Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.

Authors:  F Gudat; A Laubscher; U Otten; A Pletscher
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.